Viruses Aid In Lung Cancer Development
Posted on: Friday, 25 April 2008, 09:49 CDT
Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer.Experts agree that smoking is by far the most important factor that contributes to lung cancer development. But other factors can play a role in some cases.
In one report at the conference (Abstract No. 124PD; Friday 25th April, 09:50) Dr. Arash Rezazadeh and colleagues from the University of Louisville, Kentucky, USA, describe the results of a study on 23 lung cancer samples from patients in Kentucky.
The researchers found six samples that tested positive for the presence of human papilloma virus (HPV), the virus that also causes many cases of cervical cancer . One was later shown to be a cervical cancer that had spread to the lungs.
Of the remaining 5 virus-positive samples, two were HPV type 16, two were HPV type 11 and one was HPV type 22. "The fact that five out of 22 non-small-cell lung cancer samples were HPV-positive supports the assumption that HPV contributes to the development of non-small-cell lung cancer," the authors say.
All the patients in this study were also smokers, Dr. Rezazadeh notes. "We think HPV has a role as a co-carcinogen which increases the risk of cancer in a smoking population," he says.
In another paper (Abstract No. 125PD; Friday 25th April, 09:50), Israeli researchers suggest that measles virus may also be a factor in some lung cancers. Their study included 65 patients with non-small-cell lung cancer, of whom more than half had evidence of measles virus in tissue samples taken from their cancer.
"Measles virus is a ubiquitous human virus that may be involved in the pathogenesis of lung cancer," says lead author Prof. Samuel Ariad from Soroka Medical Center in Beer Sheva, Israel. "Most likely, it acts in modifying the effect of other carcinogens and not as a causative factor by itself."
---
Image Caption. Shot taken from lab, computer enhanced. Scale at top left. Courtesy Wikipedia
---
On the Net:
European Society for Medical Oncology
Journal of Thoracic Oncology
International Association for the Study of Lung Cancer
Related Articles
- Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
- Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds
- Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients With Type 1 and Type 2 Diabetes
- Tonsil, Tongue Cancer Linked to HPV Virus
- Published Study Finds That More Than One-Third of Patients With Type 2 Diabetes Also Suffer From Obstructive Sleep Apnea
- Generex Biotechnology Announces Commencement of a New European Clinical Study of Oral-Lyn(TM) in Patients With Type-1 Diabetes
- Metabolic Syndrome Accompanied By Hypercholesterolemia Is Strongly Associated With Proinflammatory State and Impairment of Fibrinolysis in Patients With Type 2 Diabetes: Synergistic Effects of Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fib
- New Analysis in Patients With Type 2 Diabetes From Trial With VYTORIN-TM- -Ezetimibe/Simvastatin- Presented at ADA; Consistent With Overall Study Which Showed Superior LDL Cholesterol Reduction With VYTORIN Versus Lipitor
- Adipocytokines As a Novel Target for the Anti-Inflammatory Effect of Atorvastatin in Patients With Type 2 Diabetes
- Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27
User Comments (0)


RSS Feeds